Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in China

Boehringer Ingelheim starts clinical development of fibrotic diseases treatment

Ruchika Sharma10 May 2023 4:30 PM IST

IL-11 plays a key role in fibrosis across multiple organs and pre-clinical studies have shown that anti-IL-11 treatment has the potential to stop -...

Sandoz strengthens pipeline expansion through partnership to develop, manufacture multiple biosimilars

Ruchika Sharma10 May 2023 3:30 PM IST

Basel: Sandoz has announced a multi-year partnership with Just - Evotec Biologics, the Seattle-based subsidiary of Evotec SE. The agreement covers the...

Centre Mandates QR Codes for Top Medicines, APIs: Minister

Should all medicines carry QR code for benefit of visually impaired? Delhi HC seeks Centre stand on PIL

Ruchika Sharma10 May 2023 2:30 PM IST

The petition prayed for directions to the Centre to secure effective access for visually impaired persons to medicines, food, cosmetics and other...

Novavax lays off 25 percent of workforce

Ruchika Sharma10 May 2023 1:30 PM IST

United States: Novavax said on Tuesday it will reduce its global workforce by 25% as the cash-strapped biotech pushes forward with its plans to slash...

AstraZeneca Farxiga approved in US to reduce risk of cardiovascular death, hospitalisation for heart failure to broader range of patients

Ruchika Sharma10 May 2023 12:30 PM IST

Cambridge: AstraZeneca has announced that Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death,...

Alembic Pharma wins USFDA nod for heart disease drug

Alembic Pharma gets USFDA EIR for Jarod facility

Ruchika Sharma10 May 2023 11:32 AM IST

Vadodara: Pharma major, Alembic Pharmaceuticals, has announced that the Company has received Establishment Inspection Report (EIR) from US Food...

Merck appoints Helene von Roeder as new CFO

Ruchika Sharma9 May 2023 4:30 PM IST

Darmstadt: Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board of Merck as of June 30, 2023. He...

Venus Remedies gets marketing approval for cancer drugs from Philippines, Iraq

Ruchika Sharma9 May 2023 3:30 PM IST

Having secured its first marketing authorisation from Iraq, the company expects this approval for gemcitabine from the $2.5-billion pharmaceutical...

BioNTech broadens scope as COVID shot sales slide

Ruchika Sharma9 May 2023 2:30 PM IST

New Delhi: Germany's BioNTech, Pfizer's partner on COVID-19 vaccines, said on Monday its first-quarter net income plunged on lower demand for the...

Budget Quotes - Mankind Pharma, Bharat Serum and Vaccines & Park Medi World

Shares of Mankind Pharma debut with over 20 percent premium

Ruchika Sharma9 May 2023 1:30 PM IST

The company commanded a market valuation of Rs 54,816.52 crore.

AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause Notice

AstraZeneca Koselugo gets Chinese nod for paediatric patients with neurofibromatosis type 1, plexiform neurofibromas

Ruchika Sharma9 May 2023 12:30 PM IST

In addition to China, Koselugo is also approved in the US, EU, Japan and several other countries for the treatment of paediatric patients with NF1 and...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

USFDA accepts application for Roche Vabysmo for retinal vein occlusion treatment

Ruchika Sharma9 May 2023 11:42 AM IST

Retinal vein occlusion is the second most common cause of vision loss due to retinal vascular diseases.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok